Literature DB >> 32066301

Palliative care in hematologic malignancies: a multidisciplinary approach.

Brittany Gatta1, Thomas W LeBlanc2,3.   

Abstract

Introduction: Palliative care is specialized health care focused on improving the quality of life amid serious illness. Patients with hematologic malignancies have significant needs that could be addressed by a multidisciplinary palliative care team, but the integration of palliative care into hematology is far behind that of solid tumor oncology.Areas covered: This article considers what is known about the palliative care needs of hematologic malignancy patients, shows how the multidisciplinary palliative care team could improve their care, and explores how barriers to this relationship might be overcome. The evidence to support this review comes from review of recent, relevant papers known to the authors as well as PubMed searches of additional relevant articles over the past 3 years.Expert opinion: Further cultivating this relationship requires us to thoughtfully integrate the multidisciplinary palliative care team to respond to each patient's specific disease and needs, and do so at the ideal time, to maximize benefits.

Entities:  

Keywords:  Hematologic malignancies; interdisciplinary team; multidisciplinary care; palliative care; review article

Mesh:

Year:  2020        PMID: 32066301     DOI: 10.1080/17474086.2020.1728248

Source DB:  PubMed          Journal:  Expert Rev Hematol        ISSN: 1747-4094            Impact factor:   2.929


  2 in total

1.  Intensity of care in cancer patients in the last year of life: a retrospective data linkage study.

Authors:  Xhyljeta Luta; Katharina Diernberger; Joanna Bowden; Joanne Droney; Peter Hall; Joachim Marti
Journal:  Br J Cancer       Date:  2022-05-11       Impact factor: 9.075

2.  Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM).

Authors:  Sagar Lonial; Ajay K Nooka; Praneetha Thulasi; Ashraf Z Badros; Bennie H Jeng; Natalie S Callander; Heather A Potter; Douglas Sborov; Brian E Zaugg; Rakesh Popat; Simona Degli Esposti; Julie Byrne; Joanna Opalinska; January Baron; Trisha Piontek; Ira Gupta; Reza Dana; Asim V Farooq; Kathryn Colby; Andrzej Jakubowiak
Journal:  Blood Cancer J       Date:  2021-05-26       Impact factor: 11.037

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.